|
ZNF610 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.417900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.876100E-02 |
| Normal-vs-Stage2 |
6.854100E-02 |
| Normal-vs-Stage3 |
5.535200E-03 |
| Normal-vs-Stage4 |
6.115200E-03 |
| Stage1-vs-Stage2 |
5.898600E-01 |
| Stage1-vs-Stage3 |
4.991800E-02 |
| Stage1-vs-Stage4 |
5.322400E-02 |
| Stage2-vs-Stage3 |
3.950600E-01 |
| Stage2-vs-Stage4 |
4.164800E-01 |
| Stage3-vs-Stage4 |
9.524400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.598300E-02 |
| Normal-vs-AfricanAmerican |
1.883760E-01 |
| Normal-vs-Asian |
1.083410E-01 |
| Caucasian-vs-AfricanAmerican |
9.630200E-01 |
| Caucasian-vs-Asian |
7.512600E-01 |
| AfricanAmerican-vs-Asian |
8.546200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.552400E-02 |
| Normal-vs-Female |
1.995620E-02 |
| Male-vs-Female |
5.016200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.289900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.654300E-02 |
| Normal-vs-Age(61-80Yrs) |
6.795600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.033030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.387200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.350440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.663600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.783560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.949600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.669800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.840220E-02 |
| Classical-VS-Follicular |
3.558400E-03 |
| Classical-VS-Other |
3.935400E-01 |
| Classical-VS-Normal |
1.219630E-01 |
| Tall-VS-Follicular |
9.612200E-01 |
| Tall-VS-Other |
1.932640E-01 |
| Tall-VS-Normal |
5.021800E-03 |
| Follicular-VS-Other |
1.873200E-01 |
| Follicular-VS-Normal |
2.776700E-03 |
| Other-VS-Normal |
6.058800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.802300E-02 |
| Normal-vs-N1 |
4.019600E-02 |
| N0-vs-N1 |
6.095000E-01 |
|
|
